RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Type
Retraction
Notice date
9/11/2020 0:00
Journal
The Journal of Biological Chemistry
Publisher
American Society for Biochemistry and Molecular Biology (ASBMB)